Editorial: Lung Cancer—From Mechanisms of Action and Risk Factors in Disease Onset to Management

Lung cancer is the leading cause of cancer-related mortality worldwide. This editorial accompanies the Special Issue "Lung Cancer: From Mechanisms of Action and Risk Factors in Disease Onset to Management" published in Cancers (MDPI), and introduces the twenty-one research and review articles included in the collection. The contributions span a wide spectrum of topics, from risk factors such as allostatic load and telomere biology, to molecular biomarkers including DNA methylation and serum glycopeptides, to advances in low-dose CT screening and the management of incidental findings, to targeted therapy, immunotherapy, surgical techniques, and health economics. Together, the papers highlight the multifactorial and clinically complex nature of lung cancer, and reinforce the importance of integrated, evidence-based strategies to reduce its global burden.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-03-09
DOI
https://doi.org/10.3390/cancers18050874
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Editorial: Lung Cancer—From Mechanisms of Action and Risk Factors in Disease Onset to Management

Roberto Fabiani, Irene Giacchetta
Cancers
Lung Cancer Treatments and Mutations
article

Editorial: Lung Cancer—From Mechanisms of Action and Risk Factors in Disease Onset to Management

Roberto Fabiani, Irene Giacchetta
article en

Abstract

Lung cancer is the leading cause of cancer-related mortality worldwide. This editorial accompanies the Special Issue "Lung Cancer: From Mechanisms of Action and Risk Factors in Disease Onset to Management" published in Cancers (MDPI), and introduces the twenty-one research and review articles included in the collection. The contributions span a wide spectrum of topics, from risk factors such as allostatic load and telomere biology, to molecular biomarkers including DNA methylation and serum glycopeptides, to advances in low-dose CT screening and the management of incidental findings, to targeted therapy, immunotherapy, surgical techniques, and health economics. Together, the papers highlight the multifactorial and clinically complex nature of lung cancer, and reinforce the importance of integrated, evidence-based strategies to reduce its global burden.

CancersVol. 18(5)
University of Perugia (IT), Azienda USL di Bologna (IT), Ospedale Bellaria (IT)
Good health and well-being
Openalex Percentile: Top 28%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.